Login to Your Account



Targanta Seeks $86M In IPO For Antibiotic Development

By Trista Morrison


Tuesday, May 15, 2007
As it prepares to file a new drug application for the antibiotic oritavancin in the first quarter of 2008, Targanta Therapeutics Corp. filed to raise $86.25 million in an initial public offering. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription